<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Sosei Confirms New Data Demonstrating AZD4635, a Novel A2A Receptor Antagonist, Induces Anti-Tumor Immunity Alone and in Combination With Anti-PD-L1 in Preclinical Models	</title>
	<atom:link href="https://www.novumpr.nl/2018/04/18/sosei-confirms-new-data-demonstrating-azd4635-a-novel-a2a-receptor-antagonist-induces-anti-tumor-immunity-alone-and-in-combination-with-anti-pd-l1-in-preclinical-models/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.novumpr.nl/2018/04/18/sosei-confirms-new-data-demonstrating-azd4635-a-novel-a2a-receptor-antagonist-induces-anti-tumor-immunity-alone-and-in-combination-with-anti-pd-l1-in-preclinical-models/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=sosei-confirms-new-data-demonstrating-azd4635-a-novel-a2a-receptor-antagonist-induces-anti-tumor-immunity-alone-and-in-combination-with-anti-pd-l1-in-preclinical-models</link>
	<description>NovumPR press releases</description>
	<lastBuildDate>Wed, 18 Apr 2018 08:21:32 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.2</generator>
</channel>
</rss>
